SLC25A1-related disease is typically associated with D2 and L2 hydroxyglutaric aciduria (D/L-2-HGA), a severe neurometabolic mitochondrial disease characterized by encephalopathy, severe muscle weakness, seizures, respiratory distress, psychomotor delay, and early death [93]. This evidence concerns the gene SLC25A1 and mitochondrial disease.